Form 4: CEO Corrigan Exercises Options, Sells Shares

Exponent Inc. CEO Catherine Corrigan exercised stock options and sold a portion of the acquired shares to cover exercise costs and taxes.

Summary

• Catherine Corrigan, President & CEO of Exponent Inc. (EXPO), engaged in stock option exercises and subsequent sales on February 17, 2026.
• She exercised options to acquire 3,226 shares of common stock at an exercise price of $25.405 per share.
• Concurrently, she sold 2,218 shares of common stock at an average price of $67.1646 per share to cover the option exercise price and associated taxes.
• Additionally, she exercised options for 2,380 shares of common stock at an exercise price of $29.05 per share.
• Following this, she sold 1,702 shares of common stock at an average price of $67.1378 per share, also to cover exercise costs and taxes.
• After these transactions, Corrigan directly beneficially owns 94,409 shares of Exponent Inc. common stock.
• She also holds non-qualified stock options for 12,902 shares (exercisable at $25.405, expiring 07/29/2026) and 14,278 shares (exercisable at $29.05, expiring 02/16/2027).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine insider transaction for tax and exercise cost coverage, rather than a signal of management's view on future stock performance.

Positives

• The exercise of stock options indicates that the options were in-the-money, reflecting an increase in the company's stock price since the grant date.
• The remaining beneficial ownership of 94,409 shares demonstrates continued significant alignment of the CEO's interests with shareholders.

Negatives

• The sale of shares, even if for tax and exercise cost coverage, reduces the CEO's direct equity stake in the company.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on insider transaction details.

Management Comments

• The stock sale was to cover the option exercise price and taxes.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as option exercises followed by sales to cover taxes and exercise costs, are common across industries and typically do not signal a change in company fundamentals or strategic direction. These transactions are part of standard executive compensation practices.

Comparison to Industry Standards

• This Form 4 filing details a standard insider transaction involving the exercise of stock options and subsequent sale of shares to cover associated costs and taxes. Such transactions are a common component of executive compensation packages across publicly traded companies, aligning with typical industry practices for managing equity awards. No specific comparable companies or projects are relevant for this type of routine disclosure.

Stakeholder Impact

• Shareholders: Minimal direct impact as these are routine transactions for executive compensation management.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• The remaining non-qualified stock options will become exercisable in four equal annual installments, with expiration dates of July 29, 2026, and February 16, 2027, respectively.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions (option exercises and sales to cover costs/taxes) by the CEO. It does not provide new information about the company's operational performance, financial health, or strategic outlook that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, as the filing itself does not present a compelling reason to buy or sell based solely on these transactions.

Keywords

Exponent Inc., EXPO, Catherine Corrigan, Insider Trading, Form 4, Stock Options, CEO, Share Sale, Equity Compensation